What are the recent financial highlights of GLAND PHARMA LIMITED?

GLAND PHARMA LIMITED recently reported a total revenue of ₹5,729.04 Cr and a net profit margin of 12.3%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of GLAND PHARMA LIMITED?

GLAND PHARMA LIMITED offers a dividend yield of 1.36%, with a dividend rate of ₹20.0 per share.

What are the key financial metrics of GLAND PHARMA LIMITED?

Key financial metrics include a trailing P/E ratio of 33.00678, forward P/E of 21.715118, book value of ₹533.625, price-to-book ratio of 2.6454906, and a market capitalization of ₹232.59 billion.

What does GLAND PHARMA LIMITED do?

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Gland

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Gland

Latest updates related to Gland

Sr No.	Title	Sentiment
1	Where is Ishan Kishan? Fans question wicketkeeper's absence for England T20Is India Today	🔄
2	A deep insight into the sialome of the house fly, Musca domestica , infected with the salivary gland hypertrophy virus (MdSGHV) Nature.com	🔄
3	Three global PE firms vie to buy Hyderabad’s Gland Pharma from its Chinese owner \| Company Business News Mint	🔄
4	Blackstone, Brookfield, Warburg Pincus in talks for majority stake in Gland Pharma, says report Moneycontrol	🔄
5	Intense Monitoring Makes Partial Gland Removal a Good Option for Many Prostate Cancer Patients NYU Langone Health	🔄
6	Gland Pharma shares slip 5% on disappointing revenue growth in Q3 Business Standard	🔄
7	Advances in lacrimal gland organoid development: Techniques and therapeutic applications ScienceDirect.com	🔄
8	Goldman Sachs expects Gland Pharma shares to fall back to their IPO price CNBCTV18	🔄
9	Update of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance Wiley Online Library	🔄
10	Immune signature and pathways investigation of adrenal gland diffuse large B-cell lymphoma Nature.com	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

TRIVENI DREAMFOLKS SOMATEX THYROCARE SILLYMONKS RICOAUTO HDFCAMC SIS NOIDATOLL RAJRATAN